Barclays Has Lowered Expectations for Definitive Healthcare (NASDAQ:DH) Stock Price

Key Points

• Barclays cut its price target for Definitive Healthcare from $2.75 to $1.00 and rates the stock "underweight," implying roughly a 10.3% downside from the current share price.
• The analyst picture is mixed but leans negative: MarketBeat shows a consensus rating of "Reduce" with a $3.27 consensus price target after several downgrades (including Zacks' "strong sell") and a few upgrades.
• Shares trade around $1.12 (52-week range $0.97–$4.70) with a market cap near $116M, and institutional ownership is very high (~98.7%), driven by large recent purchases from firms such as Goldman Sachs.

Definitive Healthcare (NASDAQ:DH - Get Free Report) had its target price decreased by equities researchers at Barclays from $2.75 to $1.00 in a report released on Monday,Benzinga reports. The brokerage presently has an "underweight" rating on the stock. Barclays's price target indicates a potential downside of 10.31% from the company's current price.

A number of other equities analysts have also recently issued reports on DH. Stephens cut their target price on shares of Definitive Healthcare from $3.00 to $2.00 and set an "equal weight" rating on the stock in a report on Friday, February 27th. Morgan Stanley reissued an "underperform" rating and issued a $3.50 price target on shares of Definitive Healthcare in a report on Thursday, December 18th. Canaccord Genuity Group lowered their price objective on Definitive Healthcare from $4.00 to $3.00 and set a "hold" rating for the company in a research note on Friday, February 27th. Zacks Research cut shares of Definitive Healthcare from a "hold" rating to a "strong sell" rating in a research report on Thursday, March 5th. Finally, Wall Street Zen upgraded shares of Definitive Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, March 14th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, four have given a Hold rating and four have given a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Reduce" and a consensus price target of $3.27.

Definitive Healthcare Stock Performance

Shares of NASDAQ:DH traded up $0.07 on Monday, reaching $1.12. 54,207 shares of the company's stock were exchanged, compared to its average volume of 386,016. Definitive Healthcare has a fifty-two week low of $0.97 and a fifty-two week high of $4.70. The business's 50-day moving average is $1.61 and its two-hundred day moving average is $2.47. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.41. The firm has a market capitalization of $116.48 million, a price-to-earnings ratio of -0.89 and a beta of 1.66.

Institutional Investors Weigh In On Definitive Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of the business. AQR Capital Management LLC grew its holdings in shares of Definitive Healthcare by 56.7% during the first quarter. AQR Capital Management LLC now owns 590,149 shares of the company's stock valued at $1,706,000 after buying an additional 213,562 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in Definitive Healthcare by 564.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 8,716,725 shares of the company's stock worth $25,191,000 after acquiring an additional 7,404,363 shares during the period. Jane Street Group LLC grew its stake in Definitive Healthcare by 166.0% during the 1st quarter. Jane Street Group LLC now owns 105,114 shares of the company's stock valued at $304,000 after acquiring an additional 65,597 shares in the last quarter. Creative Planning increased its holdings in shares of Definitive Healthcare by 41.7% in the 2nd quarter. Creative Planning now owns 28,628 shares of the company's stock valued at $112,000 after purchasing an additional 8,428 shares during the period. Finally, New York State Common Retirement Fund lifted its position in shares of Definitive Healthcare by 0.4% in the second quarter. New York State Common Retirement Fund now owns 766,433 shares of the company's stock worth $2,989,000 after purchasing an additional 3,066 shares in the last quarter. 98.67% of the stock is currently owned by institutional investors.

About Definitive Healthcare

Definitive Healthcare NASDAQ: DH is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company's flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.